Serina Therapeutics (SER) Shares Outstanding (Entity) (2017 - 2026)
Serina Therapeutics (SER) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 575.47 Mn |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | 16.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.39 Mn |
| Dec 31, 2025 | 10.77 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 10.15 Mn |
| Mar 31, 2025 | 9.93 Mn |
| Dec 31, 2024 | 7.36 Mn |
| Sep 30, 2024 | 8.89 Mn |
| Jun 30, 2024 | 8,514.00 |
| Mar 31, 2024 | 2.79 Mn |
| Dec 31, 2023 | 1,079.00 |
| Sep 30, 2023 | 1,079.00 |
| Jun 30, 2023 | 1,079.00 |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1,079.00 |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | 1.08 Mn |